Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Janux Therapeutics Inc (JANX)

Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,078,188
  • Shares Outstanding, K 51,851
  • Annual Sales, $ 8,080 K
  • Annual Income, $ -58,290 K
  • 60-Month Beta 3.72
  • Price/Sales 269.42
  • Price/Cash Flow N/A
  • Price/Book 3.32
Trade JANX with:

Options Overview Details

View History
  • Implied Volatility 83.63% ( -3.06%)
  • Historical Volatility 73.20%
  • IV Percentile 19%
  • IV Rank 34.94%
  • IV High 203.77% on 02/23/24
  • IV Low 19.10% on 09/19/23
  • Put/Call Vol Ratio 0.14
  • Today's Volume 58
  • Volume Avg (30-Day) 146
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 5,705
  • Open Int (30-Day) 5,435

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.32
  • Number of Estimates 4
  • High Estimate -0.21
  • Low Estimate -0.38
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +23.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.40 +2.54%
on 06/18/24
56.00 -27.86%
on 06/03/24
-6.70 (-14.23%)
since 05/17/24
3-Month
34.63 +16.66%
on 04/05/24
65.60 -38.41%
on 05/03/24
+1.59 (+4.10%)
since 03/18/24
52-Week
5.65 +615.04%
on 11/10/23
65.60 -38.41%
on 05/03/24
+27.83 (+221.40%)
since 06/16/23

Most Recent Stories

More News
5 Breakout Biotech Stocks Leading the Russell 2000 Higher

These small-cap biotech stocks are rallying hard in 2024, and still have room to keep leading the RUT higher.

JANX : 40.40 (+0.80%)
VKTX : 50.64 (-2.65%)
LBPH : 19.00 (+0.90%)
ARQT : 8.15 (+2.39%)
RNA : 38.33 (-3.21%)
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb

/CNW/ -- In the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding...

ONCY : 1.0200 (+0.99%)
CADL : 6.72 (-6.93%)
AZN : 78.42 (-1.12%)
HALO : 50.27 (+1.23%)
JANX : 40.40 (+0.80%)
ONC.TO : 1.39 (unch)
Rising Cancer Rates Drive Biotech Advancements Despite Political Hurdles

USA News Group – In the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding for President Biden’s “Cancer...

ONCY : 1.0200 (+0.99%)
ONC.TO : 1.39 (unch)
CADL : 6.72 (-6.93%)
AZN : 78.42 (-1.12%)
HALO : 50.27 (+1.23%)
JANX : 40.40 (+0.80%)
Why Janux Therapeutics Stock Is Crushing It This Week

Janux's silence about a potential acquisition deal could be golden.

JANX : 40.40 (+0.80%)
Technology Stocks Power the Broader Market Higher

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.74%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.65%. Stock indexes...

$SPX : 5,487.03 (+0.25%)
SPY : 548.49 (+0.25%)
$DOWI : 38,834.86 (+0.15%)
DIA : 389.14 (+0.14%)
$IUXX : 19,908.86 (+0.03%)
QQQ : 485.21 (+0.03%)
ZNU24 : 110-230 (-0.07%)
PARA : 9.61 (-2.24%)
AAPL : 214.29 (-1.10%)
TEAM : 153.18 (-2.20%)
NVDA : 135.58 (+3.51%)
AVGO : 1,802.52 (-1.44%)
Stock Indexes Rise in Afternoon Trade

The S&P 500 Index ($SPX ) (SPY ) is up +0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.26%. Stock indexes are higher even as bond...

$SPX : 5,487.03 (+0.25%)
SPY : 548.49 (+0.25%)
$DOWI : 38,834.86 (+0.15%)
DIA : 389.14 (+0.14%)
$IUXX : 19,908.86 (+0.03%)
QQQ : 485.21 (+0.03%)
ZNU24 : 110-230 (-0.07%)
GL : 80.40 (+0.60%)
KMX : 71.50 (-0.25%)
FAST : 64.95 (+0.84%)
GEN : 23.56 (-0.55%)
KVUE : 18.52 (-1.44%)
Stocks Slightly Higher as US Mar PPI Climbs Less Than Expected

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.36%. Stock indexes this morning...

$SPX : 5,487.03 (+0.25%)
SPY : 548.49 (+0.25%)
$DOWI : 38,834.86 (+0.15%)
DIA : 389.14 (+0.14%)
$IUXX : 19,908.86 (+0.03%)
QQQ : 485.21 (+0.03%)
ZNU24 : 110-230 (-0.07%)
TEAM : 153.18 (-2.20%)
STZ : 263.65 (+0.50%)
AZN : 78.42 (-1.12%)
NVDA : 135.58 (+3.51%)
ALPN : 64.97 (+0.02%)
Why Janux Therapeutics Stock Soared as the Market Sagged Today

One of the hotter biotech companies on the scene might be changing owners before long.

JANX : 40.40 (+0.80%)
2 Stocks That Have More Than Tripled This Year: Are They Buys?

Don't jump on the bandwaggon too quickly.

VKTX : 50.64 (-2.65%)
JANX : 40.40 (+0.80%)
After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy?

The biotech tantalized investors with a very promising data update.

AMGN : 305.99 (+0.89%)
JANX : 40.40 (+0.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Janux Therapeutics Inc. is a biopharmaceutical company. It involved in developing novel T cell engager immunotherapies. Janux Therapeutics Inc. is based in LA JOLLA, Calif.

See More

Key Turning Points

3rd Resistance Point 44.43
2nd Resistance Point 43.23
1st Resistance Point 41.81
Last Price 40.40
1st Support Level 39.19
2nd Support Level 37.99
3rd Support Level 36.57

See More

52-Week High 65.60
Fibonacci 61.8% 42.70
Last Price 40.40
Fibonacci 50% 35.63
Fibonacci 38.2% 28.55
52-Week Low 5.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar